ADRB3 and cancer: Whilst on this theme, it is known that, in ES cells, the balance between OS and antioxidants plays an important role in the efficacy of cancer therapy, and since ES cells are recognized to be susceptible to increased OS levels, Pasha et al. have proposed β3-AR as a putative target for a potential strategy in cancer therapy [269].